What are the neuropsychiatric effects of SARS-CoV-2 infection?

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 65 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 29%
  • Publisher: 71%

United Kingdom Headlines News

United Kingdom Latest News,United Kingdom Headlines

What are the neuropsychiatric effects of SARS-CoV-2 infection? medrxivpreprint UMmedschool neuropsychiatric neurology neuroscience psychiatry infection COVID19 coronavirus covid SARSCoV2

By Neha MathurSep 27 2022Reviewed by Danielle Ellis, B.Sc. In a recent study posted to the medRxiv* server, researchers investigated cognitive deficits associated with acute severe acute respiratory syndrome coronavirus 2 infection.

Those 11 participants with Long-COVID had persistent symptoms after 16 weeks of initial infection. A clinician with expertise in investigating Long-COVID interviewed these participants and ensured the status of the initial SARS-CoV-2 infection. Further, they ensured that none of the participants had any substance use disorder or were regular alcohol, marijuana, and nicotine users in the past 90 days. They used urine drug screens to screen these substances on the day of testing.

For multiple regression analysis, the team used each demographics, such as age, gender, and education, as fixed effects. The study outcomes comprised the Neuro-Quality of Life questions reports and cognitive and sensorimotor measures. Finally, the researchers used Hotelling's two-sample T2-multivariate test to examine the differences in the Neuro-QoL response profiles of all participants.

The degree of impairment across different neuropsychological domains also varied among the participants of the three study groups. The d2 Test of Attention results provides evidence of impairments in sustained attention, selective attention, and processing speed in the COVID-19 group. Likewise, the Eriksen Flanker Task also evidenced attentional dysfunction related to SARS-CoV-2 infection.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study investigates long-range RNA-RNA interactions of SARS-CoV-2Researchers explored RRIs [long-range ribonucleic acid (RNA)-RNA interactions] in SARS-CoV-2 variants of concern genomes to assess evolutionary changes in SARS-CoV-2.
Source: NewsMedical - 🏆 19. / 71 Read more »

Systemic inflammation triggered by SARS-CoV-2 found to cause human testicular injuryIn a new study, a team of researchers demonstrated that testicular injury in humans is not due to direct SARS-CoV-2 infection but more likely is an indirect effect of exposure to systemic inflammation or SARS-CoV-2 antigens.
Source: NewsMedical - 🏆 19. / 71 Read more »

Study characterizes immunological signature of SARS-CoV-2 infection in childrenA recent study has demonstrated that the clinical severity of COVID-19 in children depends on the dynamics of immune response induced by SARS-CoV-2 infection.
Source: NewsMedical - 🏆 19. / 71 Read more »

Rational treatment strategies for SARS-CoV-2 derived from human pluripotent stem cells modelsIn a recent study posted to the bioRxiv* preprint server, researchers in Australia explored the molecular mechanisms of the pulmonary and cardiac complications caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection using human stem-cell-derived cardiac and lung cells.
Source: NewsMedical - 🏆 19. / 71 Read more »

Long-term neuromuscular consequences of SARS-Cov-2 and their similarities with myalgic encephalomyelitis/chronic fatigue syndrome: results of the retrospective CoLGEM study - Journal of Translational MedicineBackground Patients with long-COVID often complain of continuous fatigue, myalgia, sleep problems, cognitive dysfunction, and post-exertional malaise. No data are available on EMG recording of evoked myopotentials (M-waves) or exercise-induced alterations in long-COVID patients, providing evidence of muscle membrane fatigue. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) develops in more than half of patients after an infectious disease, particularly viral diseases. A large proportion (around 70%) of these patients have neuromuscular disorders with M-wave alterations during and after exercise. Our hypothesis was that M-wave alterations would be also found in long-COVID patients, in association with neuromuscular symptoms, similar to ME/CFS. Methods This retrospective observational ColGEM (Covid LonG Encéphalomyelite Myalgique) study compared 59 patients with long-COVID and 55 ME/CFS patients with a history of severe infection who presented before the COVID pandemic. All of these patients underwent the same protocol consisting of a questionnaire focusing on neural and neuromuscular disorders and M-wave recording in the rectus femoris muscle before, during, and 10 min after a progressive cycling exercise. Maximal handgrip strength (MHGS) and maximal exercise power were also measured. The frequency of symptoms and magnitude of M-wave changes in the two groups were compared using non-parametric and parametric tests. Results The frequency of fatigue, myalgia, sleep problems, cognitive dysfunction, and post-exertional malaise as well as the magnitude of exercise-induced M-wave alterations were the same in the two groups. By contrast, digestive problems were less present in long-COVID. M-wave alterations were greater in ME/CFS patients as in those with long-COVID when the highest muscle strength and highest exercise performance were measured. Conclusions These high clinical and biological similarities between long-COVID and ME/CFS support the hypothesis that S
Source: BioMedCentral - 🏆 22. / 71 Read more »

Trial tests efficacy and safety of NVX-CoV2373 COVID-19 vaccine among adolescentsIn a recent study posted to the medRxiv* preprint server, researchers in the United States described the safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), tested in PREVENT-19 — a phase 3, randomized, placebo-controlled, observer-blinded trial among 12- to 17-year-old adolescents in the United States (U.S).
Source: NewsMedical - 🏆 19. / 71 Read more »